Silodosin vs Placebo in the Treatment of Female LUTS

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

278

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

December 30, 2024

Conditions

Lower Urinary Tract Symptoms

Interventions

DRUG

Silodosin

Each patient will receive 8 mg of silodosin tablet once daily.

DRUG

Placebo

Each patient will receive placebo tablet.

All Listed Sponsors

collaborator

Amiri Hospital

OTHER_GOV

lead

Mansoura University

OTHER